Work

Open-label, expanded access study of taliglucerase alfa in patients with Gaucher disease requiring enzyme replacement therapy

Year: 2020

Type: article

Study design: Clinical Trial

Source: Blood Cells Molecules and Diseases

DOI: 10.1016/j.bcmd.2020.102418

Authors: David J. Kuter, Michael Wajnrajch, Betina Hernandez, Rong Wang, Raul Chertkoff, Ari Zimran

Institutions: Massachusetts General Hospital, Pfizer (United States), Protalix BioTherapeutics (Israel), Shaare Zedek Medical Center, Bikur Cholim Hospital

Language: English

Topic: Lysosomal Storage Disorders Research

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Pfizer

OpenAlex ID: W3007834379

FWCI: 0.603

Cites: 18

Cited by: 5

Related to: 10